mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data

BACKGROUND: Previous studies suggest that different metabotropic glutamate (mGlu) receptor subtypes are potential drug targets for treating absence epilepsy. However, no information is available on mGlu3 receptors. OBJECTIVE: To examine whether (i) changes of mGlu3 receptor expression/signaling are...

Descripción completa

Detalles Bibliográficos
Autores principales: Celli, Roberta, Striano, Pasquale, Citraro, Rita, Di Menna, Luisa, Cannella, Milena, Imbriglio, Tiziana, Koko, Mahmoud, Consortium, Euro Epinomics-Cogie, De Sarro, Giovambattista, Monn, James A., Battaglia, Giuseppe, van Luijtelaar, Gilles, Nicoletti, Ferdinando, Russo, Emilio, Leo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193767/
https://www.ncbi.nlm.nih.gov/pubmed/35579153
http://dx.doi.org/10.2174/1570159X20666220509160511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193767/
https://www.ncbi.nlm.nih.gov/pubmed/35579153
http://dx.doi.org/10.2174/1570159X20666220509160511

Ejemplares similares